BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
16 déc. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Announces Partnership with Kill Cliff FC
14 déc. 2022 07h30 HE
|
BioStem Technologies, Inc.
Kill Cliff FC is One of the world’s largest MMA Training Centers with More Than 80 Professional Fighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:...
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
15 nov. 2022 16h05 HE
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
15 nov. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
26 oct. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development,...
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
10 oct. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
13 sept. 2022 07h30 HE
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
08 sept. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results
22 août 2022 16h01 HE
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on August 22, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Aug. 22, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd
16 août 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...